SCHEMBL22018202

SCHEMBL22018202

Cc1cc(C)nc(N2CC3C(=O)N(Cc4ccccc4)C(=O)C3C2)n1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
MAPT P10636 2/20 0.49
GAA P10253 1/20 0.49
HCRTR1 O43613 5/20 0.46
HCRTR2 O43614 5/20 0.46
ACHE P22303 1/20 0.45
POLB P06746 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 2/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CHRM4 P08173 1/20 0.43
TSHR P16473 2/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22018189 1.00 ALDH1A1 (0.51) ALDH1A1MAPTGAAHCRTR1HCRTR2
SCHEMBL22018288 0.92 ALDH1A1 (0.46) ALDH1A1MAPTGAAHCRTR1HCRTR2
SCHEMBL24192972 0.87 ALDH1A1 (0.51) ALDH1A1GAAACHEMEN1KMT2A
SCHEMBL1672993 0.77 HRH3 (0.52) HCRTR1HCRTR2CHRM4
SCHEMBL21963535 0.77 HRH3 (0.52) HCRTR1HCRTR2CHRM4
SCHEMBL27216329 0.76 MAPT (0.46) ALDH1A1MAPTGAAACHEPOLB
SCHEMBL24192976 0.74 HCRTR1 (0.49) HCRTR1HCRTR2KDM4EHPGDHSD17B10
SCHEMBL584067 0.74 ALDH1A1 (0.67) ALDH1A1ACHEMEN1KMT2ATSHR
SCHEMBL6096881 0.74 ALDH1A1 (0.67) ALDH1A1ACHEMEN1KMT2ATSHR
SCHEMBL22018203 0.72 KDM4E (0.44) ALDH1A1HCRTR1HCRTR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020100011-A1 IMPROVED SYNTHETIC METHODS OF MAKING FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-05-22 WO disclosed